These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17665807)

  • 1. The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of Israel.
    Lerner V; Libov I; Kaptsan A; Miodownik C; Dwolatzky T; Levine J
    Isr J Psychiatry Relat Sci; 2007; 44(1):20-8. PubMed ID: 17665807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia.
    Lerner V; Miodownik C; Kaptsan A; Vishne T; Sela BA; Levine J
    J Clin Psychiatry; 2005 Dec; 66(12):1558-63. PubMed ID: 16401157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia.
    Miodownik C; Meoded A; Libov I; Bersudsky Y; Sela BA; Lerner V
    Clin Neuropharmacol; 2008; 31(4):197-203. PubMed ID: 18670243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of dystonia in veterans on chronic antipsychotic therapy.
    Sethi KD; Hess DC; Harp RJ
    Mov Disord; 1990; 5(4):319-21. PubMed ID: 1979658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of tardive dystonia in patients with chronic schizophrenia.
    Sachdev P
    Aust N Z J Psychiatry; 1991 Dec; 25(4):446, 448. PubMed ID: 1686546
    [No Abstract]   [Full Text] [Related]  

  • 7. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
    Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporomandibular disorders among schizophrenic patients. A case-control study.
    Velasco-Ortega E; Monsalve-Guil L; Velasco-Ponferrada C; Medel-Soteras R; Segura-Egea JJ
    Med Oral Patol Oral Cir Bucal; 2005; 10(4):315-22. PubMed ID: 16056185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases.
    Chouinard G; Annable L; Ross-Chouinard A; Mercier P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):21S-26S. PubMed ID: 3220967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients.
    Sramek J; Roy S; Ahrens T; Pinanong P; Cutler NR; Pi E
    Hosp Community Psychiatry; 1991 Jun; 42(6):590-2. PubMed ID: 1677921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia--diagnostic issues, subsyndromes, and concurrent movement disorders: a study of state hospital inpatients referred to a movement disorder consultation service.
    Lauterbach EC; Carter WG; Rathke KM; Thomas BH; Shillcutt SD; Vogel RL; Moore NC; Mimbs JW; Nelson WH
    Schizophr Bull; 2001; 27(4):601-13. PubMed ID: 11824487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
    Laursen TM; Agerbo E; Pedersen CB
    J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk for cancer among patients with schizoaffective disorders.
    Levav I; Kohn R; Barchana M; Lipshitz I; Pugachova I; Weizman A; Grinshpoon A
    J Affect Disord; 2009 Apr; 114(1-3):316-20. PubMed ID: 18675461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors.
    Gureje O
    Psychol Med; 1989 Feb; 19(1):121-8. PubMed ID: 2567019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics.
    Rittmannsberger H
    Psychiatr Danub; 2008 Dec; 20(4):461-5. PubMed ID: 19011586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study.
    Tenback DE; van Harten PN; Slooff CJ; van Os J;
    Compr Psychiatry; 2007; 48(5):436-40. PubMed ID: 17707251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.